Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Baricitinib helps treat severe hair loss in people over 65.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Baricitinib may help people with long-term alopecia areata.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

The hydrogel helps heal diabetic wounds by combining antibacterial, antioxidant, and immune-boosting effects.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Valproic acid is an effective seizure medication with some temporary side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tridax procumbens may help treat diabetes.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Tofacitinib might be used to treat hair loss.

Semaglutide may help some skin disorders but can also cause skin issues.

Insulin helps heal corneal wounds and nerves in diabetic mice by activating the Wnt signaling pathway.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Zebularine improved skin structure but delayed wound healing in diabetic mice.

The drug combination was safe and showed promise in treating advanced tumors.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Upadacitinib effectively treats severe alopecia areata and is safe.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.